Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke
ConditionAcute Hemorrhagic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorXiaolin Chen, MD
About this trial
Acute hemorrhagic stroke is a series of neurosurgical diseases characterized by bleeding with high morbidity and mortality. It accounts for about 20% of all strokes worldwide and mainly includes subtypes such as intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Multimodal computed tomography including non-contrast computed tomography, computed tomography angiography and computed tomography perfusion, is of great important in understanding pathophysiological changes, evaluating prognosis and guiding interventions in these diseases.
Eligibility criteria
Qualifiers
age ≥ 18, ≤ 85 years;
presence with hemorrhagic stroke
Disqualifiers
with a history of previous history of ischemic/hemorrhagic stroke;
admission to the emergency department more than a week after symptom onset;
serious medical history or existing comorbidities;
physical disability due to previous diseases;
Trial design
Treatments tested in this trial
- Multimodal CT
Treatment groups
10,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Xiaolin Chen, MD
Lead sponsor
Beijing Tiantan Hospital
Sponsor institution
Peking University International Hospital
Collaborator
Zhangzhou Municipal Hospital of Fujian Province
Collaborator
The First Affiliated Hospital of Shanxi Medical University
Collaborator
Santai County People's Hospital
Collaborator
Jiujiang No.1 People's Hospital
Collaborator
Qin Zhou NO.1 People's Hospital
Collaborator
Sichuan Academy of Medical Sciences
Collaborator
Linyi People's Hospital
Collaborator
Source ClinicalTrials.gov